However, it is key to highlight that ACLF is a complex and multifactorial disease, and treatment efficacy, including G-CSF, is dependent on many factors including the underlying cause or trigger of ACLF, the severity of liver damage, timing for G-CSF administration or importantly the presence/absence of infection. This evidence concerns the gene CSF3 and infection.